Activated Charcoal Arsenic Triiodide Beef Lung Oen

證據等級: L5

預測適應症: 0 個

Activated Charcoal / Arsenic Triiodide / 7-Herb-Mineral Combination (9-Component Preparation): No Repurposing Predictions Available

One-Sentence Summary

This evidence pack covers a 9-ingredient preparation combining activated charcoal, arsenic triiodide, beef lung, three herbal components (Oenanthe aquatica fruit, Teucrium scorodonia flowering top), and three mineral/excipient components (silicon dioxide, sulfur, tin, tribasic calcium), with no documented approved indication in any reviewed regulatory database. The TxGNN model returned no predicted new indications for this preparation, and no clinical trials or publications were identified. This evaluation cannot proceed further until foundational data gaps are resolved.

Quick Overview

Item	Content
Original Indication	None documented
Predicted New Indication	None
TxGNN Prediction Score	N/A
Evidence Level	L5 — no actual studies; model prediction unavailable
US Market Status	Not marketed
Number of NDAs	0
Recommended Decision	Hold

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: The evidence pack contains no predicted indications, no regulatory approval, no mechanism of action data, and no supporting clinical or preclinical literature — making any repurposing evaluation impossible at this stage.

To proceed, the following is needed:

Resolve DG001 (Blocking): Retrieve the product’s package insert (仿單) from the TFDA website to establish approved indication, warnings, and contraindications — this is a prerequisite before any safety screening can begin.
Resolve DG002 (High): Query DrugBank for the mechanism of action of each active ingredient, especially arsenic triiodide (note: distinguish from the FDA-approved arsenic trioxide / Trisenox), to determine whether TxGNN can generate a meaningful repurposing signal.
Clarify preparation type: The combination of herbal, mineral, and biological components (beef lung) is characteristic of a homeopathic or traditional formulation. Confirm whether standard evidence-based drug repurposing methodology applies, or whether an alternative evaluation framework is required.
Re-run TxGNN pipeline: Once each active ingredient has a confirmed DrugBank ID and INN, run predictions per ingredient separately. Multi-ingredient mixtures without a single DrugBank ID cannot be processed as a unit by TxGNN.
Re-generate Evidence Pack (v5): After the above steps, regenerate this report with complete inputs.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.